Sandoz
Sandoz, the generic pharmaceuticals division of Novartis, is a global leader in developing, producing and marketing medicines no longer protected by patents. This broad portfolio of high-quality and cost-effective products makes affordable medicines available to patients worldwide and helps stabilise healthcare systems.
Novartis is the only major pharmaceutical company to achieve leadership positions in both patented prescription drugs and generic pharmaceuticals. Sandoz plays an increasingly important role in our strategy of offering a range of medicines to patients, physicians and healthcare providers worldwide.